Glenmark Pharmaceuticals has gained US FDA approval for its fluticasone propionate inhaler, marking a significant step in strengthening its respiratory offerings.

For many children, asthma can be a constant specter, with attacks at the most inconvenient and terrifying times. New research has now found that one inhaler containing two drugs can cut the risk of ...

United Therapeutics reported a fourth-quarter net income of $364.3 million, or $7.70 a share, compared with $301.3 million, or $6.19 a share, a year earlier. The results beat Wall Street's forecast ...

Add Yahoo as a preferred source to see more of our stories on Google. The inhaler you rely on for breathing may contribute to the planet's warming. However, there's a potential large-scale solution on ...

European regulators have given their backing to a new eco-friendly inhaler that could help curb health care’s climate impact. Drugmaker AstraZeneca said the new inhaler has a fraction of the carbon ...

A new inhaler that treats chronic obstructive pulmonary disease (COPD) and also helps reduce environmental harm has been approved for use in the UK. This inhaler is already available in India.

Early fall is when asthma flare-ups peak in the US, and a warming climate is bad news for sufferers: It means more ground-level ozone, a longer pollen season and more wildfire smoke - all triggers for ...

A new study is offering children with asthma an enhanced check-up to see whether it can bring down the overuse of inhalers.